期刊文献+

生酮饮食对MPTP小鼠帕金森病模型黑质TH、Bcl-2和cospasc-3基因表达的影响 被引量:2

Ketogenic diet affects substantia nigra TH, Bcl-2 and caspase-3 gene expressions in mouse models with 1-methyl-4-phenyl 1,2,3,6 tetrahydropyridine-induced PD
原文传递
导出
摘要 目的 研究生酮饮食对PD小鼠黑质多巴胺能神经元的抗凋亡作用。方法1-甲基-4-苯基-1、2、3、6-四氢吡啶(MPTP)腹腔注射方法制备PD模型小鼠。实验分为正常饮食模型组(正常饮食喂养后造模)、实验组(生酮饮食喂养后造模)、正常饮食组(不造模,正常饮食喂养)和生酮饮食组(不造模,生酮饮食喂养1。初次MPTP给药前及末次给药后的次日进行滚轴实验并采集血清样本检测血清酮体和血糖浓度。荧光定量PCR技术检测黑质酪氨酸羟化酶(TH)、Bcl-2及caspase-3基因水平的表达情况。结果经过生酮饮食喂养后的小鼠经MPTP给药后,死亡率较正常饮食模型组降低:滚轴实验中实验组在转盘上停留时间较正常饮食模型组延长,差异均有统计学意义(P〈0.05)。实验组和生酮饮食组的血清酮体浓度较其他2组明显升高,差异有统计学意义(P〈0.05)。荧光定量PCR检测发现,与正常饮食模型组相比,实验组黑质中册基因的表达明显升高,抗凋亡作用的Bcl-2基因也明显升高,促凋亡作用的caspase-3基因的表达明显减少,差异均有统计学意义(P〈0.05)。结论生酮饮食逆转了MPTP给药后的黑质中Bcl-2基因表达的下调和caspase-3基因表达的上调.进而抑制了多巴胺能神经元的凋亡,起到了保护黑质多巴胺能神经元的作用。 Objective To investigate the anti-apoptotic effect of ketogenic diet (KD) on substantia nigra dopaminergic neurons in mouse models with PD. Methods Eight-week-old male C57BL/6 mice, weighting 24-26 g, were randomly divided into normal diet and model group (1-methyl-4-phenyl 1,2,3,6 tetrahydropyridine [MPTP]), experimental group (KD+MPTP), normal diet group and KD group. Mouse models with PD were established by subjecting them to intraperitoneal injection of MPTP. All the mice in the normal diet group and MPTP group were fed with normal diet and were flee to access food, while mice in the KD+MPTP and KD group were fed with KD every other day for 1 month. All mice were trained for rotarod test during the feeding and time on the rotarod was formally recorded 1 d before the drug injection. One d after the last injection, rotarod test was implemented again, and then, samples of blood were collected for analysis of serum concentrations of ketone bodies and glucose. The levels of substantia nigra TH, Bcl-2 and caspase-3 gene expressions were examined by fluorescence quantitative PCR. Results The mice in the KD+MPTP group not only enjoyed a lower mortality rate, but also performed better in the rotarod test than mice in the MPTP group. The concentrations of serum ketone bodies in the KD group and KD+MPTP group were significantly higher than those in the other 2 groups (P〈0.05). Compared with the MPTP group, the levels of TH and Bc1-2 gene expressions in the KD+MPTP group were significantly increased, while the level of caspase-3 gene expression was significantly reduced (P〈0.05). Conclusion KD reverses the effect of MPTP administration by decreasing the level of Bc1-2 gene expression and increasing the level of caspase-3 gene expression, therefore, it inhibits the apoptosis of dopaminergic neurons and plays a vital role in the protection of substantia nigra dopaminergic neurons.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2010年第10期1018-1022,共5页 Chinese Journal of Neuromedicine
关键词 帕金森病 生酮饮食 酪氨酸羟化酶 BCL-2 CASPASE-3 Parkinson's disease Ketogenic diet 1-methyl-4-phenyl 1,2,3,6 tetrahydropyridine Bcl-2 gene Caspase-3 gene
  • 相关文献

参考文献15

  • 1Wilder RM.The effects of ketonemia on the course of epilepsy[J].Mayo Clin Bull,1921,2:307-308.
  • 2姚庆和,张华,高国栋.帕金森病小鼠模型行为学检测方法的比较研究[J].中国实验动物学报,2006,14(4):264-270. 被引量:19
  • 3Maswood N,Young J,Tilmont E,et al.Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease[J].Proc Natl Acad Sci U S A,2004,101(52):18171-18176.
  • 4Vanitallie TB,Nonas C,Di Rocco A,et al.Treatment of Parkinson disease with diet-induced hyperketonemia:a feasibility study[J].Neurology,2005,64(4):728-730.
  • 5de Lau LM,Bornebroek M,Witteman JC,et al.Dietary fatty acids and the risk of Parkinson disease:the Rotterdam study[J].Neurology,2005,64(12):2040-2045.
  • 6姚庆和,高国栋.MPTP的毒性机制与帕金森病动物模型[J].国外医学(神经病学.神经外科学分册),2004,31(1):45-48. 被引量:9
  • 7Rodnitzky RL.Can calcium antagonists provide a neuroprotective effect in Parkinsonfs disease?[J].Drugs,1999,57(6):845-849.
  • 8Kaminski Schierle GS,Hansson O,Brundin P.Flunarizine improves the survival of grafted dopaminergic neurons[J].Neuroscience,1999,94(1):17-20.
  • 9Nemoto C,Hida T,Arai R.Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain:a triple-labeling immunohistochemical study[J].Brain Res,1999,30,846 (1):129-136.
  • 10McMahon A,Wong BS,Iacopino AM,et al.Calbindin-D28kbuffers intracellular calcium and promotes resistance to degeneration in PC12 cells[J].Brain Res Mol Brain Res,1998,54(1):56-63.

二级参考文献33

  • 1高云朝,林祥通.MPTP帕金森病动物模型研究进展[J].中国实验动物学报,2005,13(4):261-265. 被引量:13
  • 2Perez V, Unzeta M. PF 9601N [N-(2-propynyl) -2-(5-benzyloxy-indolyl )methylamine], a new MAO - B inhibitor,attenuates MPTP - induced depletion of striatal dopamine levels in C57/BL6 mice. Neurochem Int,2003,42(3) :221 - 229.
  • 3Bezard E, Gross CE, Fourier MC, et al. Absence of MPTP- induced neuronal death in mice lacking the dopamine transporter. Exp Neurol,1999,155(2) :268 - 273.
  • 4Staal RG, Hogan KA, Liang CL, et al. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2) : rat versus mouse differences in sequestration of 1-methyl -4-phenylpyridinium. J Pharmacol Exp Ther, 2000, 293(2) :329 - 335.
  • 5Marey - Semper I, Gelman M, Levi - Strauss M. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J Neurosci, 1995, 15(9) :5912 - 5918.
  • 6Leret ML, San Millan JA, Fabre E, et al. Deprenyl protects from MPTP-induced Parkinson - like syndrome and glutathione oxidation in rat striatum. Toxicology, 2002,170(3) : 165 - 171.
  • 7Klivenyi P, Andreassen OA, Ferrante RJ, et al. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate,3 - nitropropionic acid, and 1-methyl -4-phenyl-1,2, 5,6-tetrahydropyridine. J Neurosci, 2000, 20(1) : 1 - 7.
  • 8Andreassen OA, Ferrante RJ, Dedeoglu A, et al. Mice with a partial deficiency of manganese supemxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Exp Neurol, 2001, 167(1) :189 - 195.
  • 9Kunikowska G, Jenner P. Alterations in m - RNA expression for Cu, Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP - treated marmosets and patients with Parkinson' s disease.Brain Res, 2003, 968(2) :206 - 218.
  • 10Kurosaki R, Muramatsu Y, Michimata M, et al. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol Res, 2002, 24(7) :655 - 662.

共引文献26

同被引文献29

  • 1岳春江,程秀华,余轶娴,陈思,杨诗勤.饮食管理在帕金森病患者中的应用[J].中国临床护理,2014,6(5):394-395. 被引量:3
  • 2徐珊珊,侯芳,徐敏宁.帕金森病患者的饮食指导[J].现代护理,2005,11(2):103-104. 被引量:8
  • 3椎尾,康,刘芳.帕金森病的饮食和运动疗法[J].日本医学介绍,2005,26(10):464-465. 被引量:1
  • 4王刚,陈生弟.帕金森病的营养支持[J].中国临床营养杂志,2007,15(1):51-55. 被引量:10
  • 5KossoffEH, rauss GL, Me Grogan JR, et al. Efficacy of the Atkins diet as therapy for intractable epilepsy[J]. Neurology, 2003, 61(12): 1789-179l.
  • 6Kossoff EH, McGrogan JR, Bluml RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy [J]. Epilepsia, 2006, 47(2): 421-424.
  • 7Carrette E, Vonck K, De Herdt V, et al. A pilot trial with modified Atkins' diet in adult patients with refractory epilepsy [J]. Clin Neurol eurosurg, 2008, 110(8): 797-803.
  • 8Ito S, Oguni H,lto Y, et al. Modified Atkins diet therapy for a case with glucose transporter type I deficiency syndrome[J]. Brain Dev, 2008, 30(3): 226-228.
  • 9KossoffEH, Rowley H, Sinha SR, et al. A prospective study of the modified Atkins diet for intractable epilepsy in adults[J]. Epilepsia, 2008a, 49(2): 316-319.
  • 10KossoffEH, Dorward JL, Molinero MR, et al. The modified Atkins diet: a potential treatment for developing countries [J]. Epilepsia, 2008,49(9): 1646-1647.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部